Voci, S.; Gagliardi, A.; Ambrosio, N.; Salvatici, M.C.; Fresta, M.; Cosco, D.
Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity. Pharmaceutics 2023, 15, 180.
https://doi.org/10.3390/pharmaceutics15010180
AMA Style
Voci S, Gagliardi A, Ambrosio N, Salvatici MC, Fresta M, Cosco D.
Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity. Pharmaceutics. 2023; 15(1):180.
https://doi.org/10.3390/pharmaceutics15010180
Chicago/Turabian Style
Voci, Silvia, Agnese Gagliardi, Nicola Ambrosio, Maria Cristina Salvatici, Massimo Fresta, and Donato Cosco.
2023. "Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity" Pharmaceutics 15, no. 1: 180.
https://doi.org/10.3390/pharmaceutics15010180
APA Style
Voci, S., Gagliardi, A., Ambrosio, N., Salvatici, M. C., Fresta, M., & Cosco, D.
(2023). Gliadin Nanoparticles Containing Doxorubicin Hydrochloride: Characterization and Cytotoxicity. Pharmaceutics, 15(1), 180.
https://doi.org/10.3390/pharmaceutics15010180